deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03172026

Maraviroc to Augment Rehabilitation Outcomes After Stroke (MAROS)

Sponsor: University of California, Los Angeles

Conditions Stroke
Interventions Maraviroc 300 mg Placebo 300 mg Rehabilitation therapy
Updated 7 times since 2017 Last updated: Jul 12, 2021 Started: Aug 1, 2019 Primary completion: Oct 1, 2020 Completion: Oct 1, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor recruitment for each site, partly related to Covid epidemic.

Other terminated trials from University of California, Los Angeles

See all terminations from University of California, Los Angeles

Other Stroke trials with similar outcome

Browse all Stroke trials

This PHASE2/PHASE3 trial investigates Stroke and is currently terminated or withdrawn. University of California, Los Angeles leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotRecruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotRecruiting~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotRecruiting~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Sep 2021 — Jul 2024 [monthly]

    Terminated PHASE2_PHASE3

    Status: Recruiting → Terminated

  4. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2_PHASE3

  5. Oct 2019 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Oct 2019 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

  2. Jul 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, Los Angeles
Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations